HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Vision Rehabilitation
Vision Rehabilitation
Rehabilitation (literally, "becoming able again") aids patients in regaining physical, social, emotional, and spiritual independence, as well as improving their quality of life. Rehabilitation aims to enhance function and independence via adaptation rather than undoing or reversing the cause of harm. A medical rehabilitation to improve vision or low vision is known as vision rehabilitation (also known as vision rehab). In other words, it is the process of regaining functional capacity and increasing quality of life and independence in someone who has lost their vision due to disease or injury. Low vision rehabilitation allows optometrists to help their patients improve their function, independence, and general health.
- Clinical Studies and Treatments
- Neurological Approach
- Chemical Treatments
- Physical Approach
Committee Members
John David Bullock
Wright State University, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Kasra Rezaei
University of Washington, United States IOC 2025 Speakers
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Ultra-Widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States